Drug resistance pulmonary tuberculosis in the eastern province of Saudi Arabia

Citation
Am. Al-rubaish et al., Drug resistance pulmonary tuberculosis in the eastern province of Saudi Arabia, SAUDI MED J, 22(9), 2001, pp. 776-779
Citations number
25
Categorie Soggetti
General & Internal Medicine
Journal title
SAUDI MEDICAL JOURNAL
ISSN journal
03795284 → ACNP
Volume
22
Issue
9
Year of publication
2001
Pages
776 - 779
Database
ISI
SICI code
0379-5284(200109)22:9<776:DRPTIT>2.0.ZU;2-R
Abstract
Objectives: To evaluate the prevalence and pattern of antituberculous drug resistance and patients with pulmonary tuberculosis in the Eastern Province and its impact on the tuberculosis control program. Methods: Patients with pulmonary tuberculosis, proven by culture, admitted to Dammam Chest Hospital from November 1993 through May 1996 were reviewed. Patients who had at least one documented isolate of mycobacterium tubercul osis resistant to at least one standard anti-tuberculosis drug were identif ied. Medical records were reviewed and information was retrieved regarding age, sex, nationality, history of previous tuberculosis, human immune defic iency status, and results of direct smear and chest radiograph abnormalitie s. Results: A total of 411 cases of culture positive pulmonary tuberculosis wi th drug susceptibility testing, were identified during the period mentioned , of these 123 (30%) were Saudi nationals and 228 (70%) were non-Saudis. Dr ug resistance to at least one drug was observed in 43 (10.5%) patients, res istance to isoniazid alone was observed in 25 (6%) patients, whereas resist ance to rifampicin was noted in only one (0.2%) patient, and to streptomyci n in 3 (1%) patients, multidrug resistance was observed in 11 (3%) patients . Conclusion: The study has shown that the overall drug resistance rate of 10 .5% in the Eastern Province of Saudi Arabia is the lowest reported in the K ingdom, compared with Riyadh (13%), Taif (23%) and Gizan (44%). However, it appears to be similar to that reported in neighboring countries. In light of the study findings, and as per the recommendation of the World Health Or ganization, we suggest that a 4-drug regimen, as an initial treatment for p ulmonary tuberculosis should be maintained, as resistance to isoniazid is s till higher than the cut off value of 4%, and susceptibility testing for fi rst line antituberculosis drugs should be carried out whenever possible. We also recommend applying stricter medical criteria for tuberculosis screeni ng in newcomers, and for Saudi nationals, application of directly observed therapy should be a priority.